Sean Ellis is Director of Entera Bio Ltd.. Currently has a direct ownership of 127,627 shares of ENTX, which is worth approximately $238,662. The most recent transaction as insider was on Oct 02, 2024, when has been sold 7,466 shares (Ordinary Shares, par value NIS 0.0000769 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K
25.0% 3M change
25.0% 12M change
Total Value Held $238,662

Sean Ellis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 02 2024
BUY
Grant, award, or other acquisition
-
7,466 Added 5.53%
127,627 Ordinary Shares, par v...
Aug 27 2024
BUY
Grant, award, or other acquisition
-
18,061 Added 13.07%
120,161 Ordinary Shares, par v...
Aug 21 2023
BUY
Open market or private purchase
$24,000 $0.6 p/Share
40,000 Added 28.15%
102,100 Ordinary Shares, par v...
Nov 11 2022
BUY
Open market or private purchase
$15,900 $0.53 p/Share
30,000 Added 32.57%
62,100 Ordinary Shares, par v...
Jul 21 2022
BUY
Open market or private purchase
$24,436 $1.64 p/Share
14,900 Added 31.7%
32,100 Ordinary Shares, par v...
Jan 18 2022
BUY
Open market or private purchase
$28,100 $2.81 p/Share
10,000 Added 50.0%
10,000 Ordinary Shares, par v...
SE

Sean Ellis

Director
Jerusalem, L3

Track Institutional and Insider Activities on ENTX

Follow Entera Bio Ltd. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENTX shares.

Notify only if

Insider Trading

Get notified when an Entera Bio Ltd. insider buys or sells ENTX shares.

Notify only if

News

Receive news related to Entera Bio Ltd.

Track Activities on ENTX